These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10509495)

  • 1. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.
    Goulis J; Leandro G; Burroughs AK
    Lancet; 1999 Sep; 354(9184):1053-60. PubMed ID: 10509495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. URSO-panacea or placebo?
    Neuberger J
    Hepatology; 2000 Apr; 31(4):1027-8. PubMed ID: 10733564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gluud C; Christensen E
    Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses.
    Gong Y; Huang Z; Christensen E; Gluud C
    Am J Gastroenterol; 2007 Aug; 102(8):1799-807. PubMed ID: 17459023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bezafibrate for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.
    Boberg KM; Wisløff T; Kjøllesdal KS; Støvring H; Kristiansen IS
    Aliment Pharmacol Ther; 2013 Oct; 38(7):794-803. PubMed ID: 23915021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Combes B; Luketic VA; Peters MG; Zetterman RK; Garcia-Tsao G; Munoz SJ; Lin D; Flye N; Carithers RL
    Am J Gastroenterol; 2004 Feb; 99(2):264-8. PubMed ID: 15046215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.
    Battezzati PM; Zuin M; Crosignani A; Allocca M; Invernizzi P; Selmi C; Villa E; Podda M
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1427-34. PubMed ID: 11552915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
    Zhang Y; Li S; He L; Wang F; Chen K; Li J; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():2757-66. PubMed ID: 26045661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine for primary biliary cirrhosis.
    Gong Y; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD004481. PubMed ID: 15106254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
    Almasio PL; Floreani A; Chiaramonte M; Provenzano G; Battezzati P; Crosignani A; Podda M; Todros L; Rosina F; Saccoccio G; Manenti F; Ballardini G; Bianchi FP; Scheuer PJ; Davies SE; Craxì A
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1645-52. PubMed ID: 11121914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.
    Poupon RE; Lindor KD; Cauch-Dudek K; Dickson ER; Poupon R; Heathcote EJ
    Gastroenterology; 1997 Sep; 113(3):884-90. PubMed ID: 9287980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
    Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M
    Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
    Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
    Corpechot C; Carrat F; Bonnand AM; Poupon RE; Poupon R
    Hepatology; 2000 Dec; 32(6):1196-9. PubMed ID: 11093724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis.
    Yin Q; Li J; Xia Y; Zhang R; Wang J; Lu W; Zhou Y; Zheng Y; Abudumijiti H; Chen R; Chen K; Li S; Liu T; Wang F; Lu J; Zhou Y; Guo C
    Drug Des Devel Ther; 2015; 9():5407-19. PubMed ID: 26491252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V; Michael S; Prego V
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.